Samsara BioCapital, L.P. → ALUMIS INC. ALMS

Stake: 5.40% Shares: 6,345,219 CUSIP: 022307102 Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 5.50

11,230,693 shares short · +25.3% vs prior

Post-Filing Returns · since 2026-01-09 on ALMS

+1 day

+7.8%

+5 days

+24.4%

+30 days

+33.5%

+60 days

+43.7%

+90 days

+17.3%

+180 days

—

Anchor price 19.56 on closest trading day on/after 2026-01-09. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on ALUMIS INC.

Filed	Form	Filer	Stake	Shares
2026-04-03	SCHEDULE 13D/A	Foresite Capital Fund VI LP	12.70%	4,247,670	view →
2026-01-12	SCHEDULE	Foresite Capital Fund VI LP	14.10%	16,189,804	view →
2025-02-10	SCHEDULE	AyurMaya Capital Management Company, LP	22.50%	10,645,966	view →

Other Filings by Samsara BioCapital, L.P.

Filed	Form	Issuer	Stake	Shares
2025-03-17	SCHEDULE	Mineralys Therapeutics, Inc. MLYS	9.10%	5,736,305	view →
2024-10-07	SC	Scholar Rock Holding Corp SRRK	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →